Belite Bio (BLTE) Total Current Liabilities (2021 - 2025)

Belite Bio's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $9.9 million for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 63.34% year-over-year to $9.9 million; the TTM figure through Dec 2025 stood at $9.9 million (up 63.34% YoY), while the FY2025 annual figure was $9.9 million, up 63.34% from the prior year.
• Total Current Liabilities was $9.9 million for Q4 2025 at Belite Bio, up from $8.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $9.9 million in Q4 2025 to a low of $1.6 million in Q4 2021.
• Historically, Total Current Liabilities has averaged $5.2 million across 5 years, with a median of $4.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities grew 28.69% in 2022, then surged 72.67% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $1.6 million in 2021, then advanced by 28.69% to $2.1 million in 2022, then soared by 72.67% to $3.6 million in 2023, then jumped by 66.53% to $6.0 million in 2024, then soared by 63.34% to $9.9 million in 2025.
• The last three Total Current Liabilities figures came in at $9.9 million (Q4 2025), $8.1 million (Q3 2025), and $6.0 million (Q4 2024), per Business Quant data.